Bank of America reduces its stake in ABIVAX

Bank of America Corporation has exceeded its ownership threshold in ABIVAX. On October 9, 2026, it reported holding 4.92% of the share capital and 4.85% of the voting rights, a decrease from the previously held 5% threshold. This decrease resulted from a sale of shares on the market and a reduction in shares held through fungibility.

The shares are held through various entities within the bank, including Merrill Lynch International and BofA Securities, Inc. The detailed breakdown reveals a variety of contracts, such as "rights of use" and "put options." These mechanisms illustrate the complexity of equity management by large financial institutions.

In addition to shares, Merrill Lynch International and Bank of America, National Association hold swaps that allow them to adjust their positions in ABIVAX. These financial instruments, some of which are redeemable in cash, offer long-term strategic flexibility.